MicroRNA-21 expression in CD4 T cells is regulated by STAT3 and Is pathologically involved in sézary syndrome

Journal of Investigative Dermatology

Volumn 131, Issue 3, 2011, Pages 762-768

  Van Der Fits, Leslie ^a   Van Kester, Marloes S ^a   Qin, Yongjun ^a   Out Luiting, Jacoba J ^a   Smit, Fiona ^a   Zoutman, Willem H ^a   Willemze, Rein ^a   Tensen, Cornelis P ^a   Vermeer, Maarten H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 21; MICRORNA 21; STAT3 PROTEIN;

AGED; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEZARY CELL; SEZARY SYNDROME; UPREGULATION;

EID: 79951516643     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.349     Document Type: Article

References (32)

1. Blaskovich MA, Sun J, Cantor A et al. (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63:1270-9 (Pubitemid 36348705)
2. Calin GA, Croce CM (2007) Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest 117:2059-66 (Pubitemid 47219545)
3. Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029-33 (Pubitemid 40994386)
4. Chui DT, Hammond D, Baird M et al. (2003) Classical Hodgkin lymphoma is associated with frequent gains of 17q. Genes Chromosomes Cancer 38:126-36 (Pubitemid 37093430)
5. Davis BN, Hilyard AC, Lagna G et al. (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454:56-61 (Pubitemid 351931982)
6. Eriksen KW, Kaltoft K, Mikkelsen G et al. (2001) Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia 15:787-93 (Pubitemid 32492702)
7. Fei J, Lan F, Guo M et al. (2008) Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth. J Drug Target 16: 688-93
8. Frankel LB, Christoffersen NR, Jacobsen A et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283:1026-33
9. Fujita S, Ito T, Mizutani T et al. (2008) miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 378:492-504
10. Jing N, Tweardy DJ (2005) Targeting Stat3 in cancer therapy. Anticancer Drugs 16:601-7 (Pubitemid 40863092)
11. Kaltoft K, Bisballe S, Rasmussen HF et al. (1987) A continuous T-cell line from a patient with Sezary syndrome. Arch Dermatol Res 279:293-8 (Pubitemid 17092161)
12. Kasahara K, Taguchi T, Yamasaki I et al. (2002) Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization. Cancer Genet Cytogenet 137:59-63
13. Krichevsky AM, Gabriely G (2009) miR-21: a small multi-faceted RNA. J Cell Mol Med 13:39-53
14. Lawrie CH, Saunders NJ, Soneji S et al. (2008) MicroRNA expression in lymphocyte development and malignancy. Leukemia 22:1440-6 (Pubitemid 352006091)
15. Lee EJ, Baek M, Gusev Y et al. (2008) Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 14:35-42
16. Li J, Huang H, Sun L et al. (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15:3998-4008
17. Loffler D, Brocke-Heidrich K, Pfeifer G et al. (2007) Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110:1330-3 (Pubitemid 47281433)
18. Marzec M, Halasa K, Kasprzycka M et al. (2008) Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells. Cancer Res 68:1083-91 (Pubitemid 351272226)
19. Meng F, Henson R, Lang M et al. (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130:2113-29 (Pubitemid 43816961)
20. Meng F, Henson R, Wehbe-Janek H et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647-58 (Pubitemid 47187346)
21. Nielsen M, Kaestel CG, Eriksen KW et al. (1999) Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 13:735-8 (Pubitemid 29243625)
22. Scarisbrick JJ, Woolford AJ, Russell-Jones R et al. (2000) Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 95:2937-42 (Pubitemid 30235906)
23. Si ML, Zhu S, Wu H et al. (2007) miR-21-mediated tumor growth. Oncogene 26:2799-803 (Pubitemid 46663837)
24. van Kester MS, Out-Luiting JJ, von dem Borne PA et al. (2008) Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells. J Invest Dermatol 128:1691-5 (Pubitemid 351847375)
25. Vermeer MH, van DR, Dijkman R et al. (2008) Novel and highly recurrent chromosomal alterations in Sezary syndrome. Cancer Res 68:2689-98 (Pubitemid 351556266)
26. Willemze R, Jaffe ES, Burg G et al. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-85 (Pubitemid 40656118)
27. Wu GJ, Sinclair CS, Paape J et al. (2000) 17q23 amplifications in breast cancer involve the PAT1, RAD51C, PS6K, and SIGma1B genes. Cancer Res 60:5371-5
28. Yamanaka Y, Tagawa H, Takahashi N et al. (2009) Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 114:3265-75
29. Yendamuri S, Calin GA (2009) The role of microRNA in human leukemia: a review. Leukemia 23:1257-63
30. Yu H, Jove R (2004) The STATs of cancer-new molecular targets come of age. Nat Rev Cancer 4:97-105 (Pubitemid 38198738)
31. Zhang C, Li B, Gaikwad AS et al. (2008) Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. J Invest Dermatol 128:2728-35
32. Zhu S, Si ML, Wu H et al. (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328-36 (Pubitemid 47100416)